CEBPA and acute myeloid leukemia: Mouse models of CEBPA mutated AML showed that homozygous C-terminal mutations promote the expansion of pre-leukemic HSCs but impair myeloid differentiation, whereas N-terminal mutations do not impact on proliferation and preserve myeloid commitment.